{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:03:41Z","timestamp":1786118621790,"version":"build-2736575974"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1097\/wco.0b013e328013dbc8","type":"journal-article","created":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T04:02:53Z","timestamp":1168315373000},"page":"71-77","source":"Crossref","is-referenced-by-count":10,"title":["Stroke and the statistics of the aspirin\/clopidogrel secondary prevention trials"],"prefix":"10.1097","volume":"20","author":[{"given":"George","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John W","family":"Krakauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S","family":"Coffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210206","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","article-title":"A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).","volume":"348","year":"1996","journal-title":"Lancet"},{"key":"R2-13-20210206","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJMoa010746","article-title":"Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"R3-13-20210206","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(04)16721-4","article-title":"Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial","volume":"34","author":"Diener","year":"2004","journal-title":"Lancet"},{"key":"R4-13-20210206","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1538-7836.2005.01439.x","article-title":"Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke\/TIA?: No","volume":"3","author":"Hankey","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R5-13-20210206","first-page":"1136","article-title":"Is clopidogrel the antiplatelet drug of choice for high-risk patients with stroke\/TIA: Yes.","volume":"1133-","author":"Diener","year":"2005","journal-title":"J Thromb Haemost"},{"key":"R6-13-20210206","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(96)00308-5","article-title":"European Stroke Prevention Study 2 Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke","volume":"143","author":"Diener","year":"1996","journal-title":"J Neurol Sci"},{"key":"R7-13-20210206","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa060989","article-title":"Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events","volume":"354","author":"Bhatt","year":"2006","journal-title":"N Engl J Med"},{"key":"R8-13-20210206","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/S0140-6736(06)68734-5","article-title":"ESPRIT Study Group. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial","volume":"367","author":"Halkes","year":"2006","journal-title":"Lancet"},{"key":"R9-13-20210206","first-page":"29","article-title":"Atillio Maseri, MD, FACC, discusses the role of biological clinical research in cardiovascular disease and the move from megatrials to personalized patient management.","volume":"113","author":"Maseri","year":"2006","journal-title":"Circulation"},{"key":"R10-13-20210206","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0140-6736(05)17709-5","article-title":"Treating individuals 2. Subgroup analysis in randomized controlled trials: importance, indications, and interpretation","volume":"365","author":"Rothwell","year":"2005","journal-title":"Lancet"}],"container-title":["Current Opinion in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/WCO.0b013e328013dbc8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:17:54Z","timestamp":1786033074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00019052-200702000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/wco.0b013e328013dbc8","relation":{},"ISSN":["1350-7540"],"issn-type":[{"value":"1350-7540","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}